FILTER

LATEST INTERVIEWS

Tom McCulley

CEO, ANGLO AMERICAN PERU
"Anglo American’s agreement with ENGIE Energía Peru sends a message to the mining industry and to Peru that renewable energy is feasible, and we are very proud to be the first mine in the country that powers its entire operation via renewables."

Kevin Brady

DIRECTOR OF SUSTAINABILITY SERVICES, AUSENCO
"The initial raison d’être of Ausenco was to be more efficient in the design of mineral processing – finding a better way. If you are more efficient in designing and building, it naturally leads to less use of resources and less environmental impact."

Javier Del Rio

VP BUSINESS UNIT SOUTH AMERICA, HUDBAY MINERALS INC.
"Hudbay is trying to bring in a multi-stakeholder approach that delivers investment into the Chumbivilcas region from many sources. Sustained investment and development is needed in the province, and this cannot be achieved by one company alone."

Gonzalo Covarrubias

GENERAL MANAGER, WSP PERU
"Large projects are a multidisciplinary challenge, and their development must include all the stakeholders; these groups cannot work in silos. Furthermore, how we exploit resources and develop future mining operations must consider climate change, wealth-creation for communities, and evolving technologies."

Helio Coelho

GLOBAL CHEMICAL SALES DIRECTOR – LATIN AMERICA, BDP INTERNATIONAL
BDP International discusses how innovation and technology can overcome logistical bottlenecks.

Peter J. Cashin

PRESIDENT & CEO, IMPERIAL MINING GROUP LTD
Imperial Mining speaks about developing its strategic rare earth asset in Québec.

Massimo Scaccabarozzi

PRESIDENT, FARMINDUSTRIA
Farmindustria speaks to GBR about the importance of pharmaceuticals to the Italian economy and society.

Shankar Musunuri

CHAIRMAN, CEO & CO-FOUNDER, OCUGEN
Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.

Massimiliano Rocchi

SENIOR DIRECTOR ITALY AND GREECE, ACCORD HEALTHCARE ITALIA
Accord Healthcare Italia explains the challenges and opportunities for generics producers in Italy.

Luca Crippa

CEO & MANAGING DIRECTOR, IBSA FARMACEUTICI
Instituto Biochimico, with 2,000 global employees, is attempting to take generics to the next level and continue to expand around the world.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS